Anti-Angiogenic Therapy for Colorectal Cancer: On the Way to Getting Better!

被引：6

作者：

He, Kuifeng ^{[1
]}

Jin, Ketao ^{[1
]}

Wang, Haohao ^{[1
]}

Teng, Lisong ^{[1
]}

机构：

[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Ctr Canc, Hangzhou 310003, Zhejiang, Peoples R China

来源：

HEPATO-GASTROENTEROLOGY | 2012年 / 59卷 / 116期

关键词：

Antiangiogenesis agents; Combination therapy; Colorectal neoplasms; Vascular disrupting agents; Metronomic chemotherapy; Surrogate markers; RECOMBINANT HUMAN ENDOSTATIN; ADVANCED SOLID TUMORS; METRONOMIC CHEMOTHERAPY; PHASE-I; ANTIANGIOGENIC THERAPY; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; ENDOTHELIAL-CELLS; DRUG-RESISTANCE; PLUS IRINOTECAN;

D O I：

10.5754/hge10722

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Based on the theory that tumor growth and metastasis depend on vessels to provide oxygen and nutrients, antiangiogenic therapy was thought as a promising approach to cure cancer: Bevacizumab is the first validated angiogenesis inhibitor, when combined with conventional treatments, which can enhance antitumor effects and prolong survival for patients with colorectal cancer. However, recent years, bevacizumab and other angiogenesis inhibitors are more discussed with drug-resistance and the diverse test results. Fortunately, antiangiogenic strategy is more than bevacizumab and more than anti-vascular endothelial growth factor. Dozens of compounds that potently inhibit neoplastic blood vessels formation with different mechanisms have been developed, and many of them are being tested clinically for colorectal cancer: This review will numerate the principal antiangiogenic drugs with various mechanisms, recapitulate the information of studying these drugs for colorectal cancer treatment and try to clue better usage of antiangiogenic therapy for patients with colorectal cancer in the future.

引用

页码：1113 / 1117

页数：5

共 67 条

[1] Vascular integrins in tumor angiogenesis:: Mediators and therapeutic targets [J].

Alghisi, Gian Carlo ;

Rueegg, Curzio .

ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 2006, 13 (02) :113-135

[2] Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation [J].

Allegrini, Giacomo ;

Di Paolo, Antonello ;

Cerri, Elisa ;

Cupini, Samanta ;

Amatori, Federica ;

Masi, Gianluca ;

Danesi, Romano ;

Marcucci, Lorenzo ;

Bocci, Guido ;

Del Tacca, Mario ;

Falcone, Alfredo .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (05) :585-593

[3]

[Anonymous], ASCO M

[4] Novel Microtubule Polymerization Inhibitor with Potent Antiproliferative and Antitumor Activity [J].

Arora, Sonia ;

Wang, Xin I. ;

Keenan, Susan M. ;

Andaya, Christina ;

Zhang, Qiang ;

Peng, Youyi ;

Welsh, William J. .

CANCER RESEARCH, 2009, 69 (05) :1910-1915

[5] Bortezomib induces autophagic death in proliferating human endothelial cells [J].

Belloni, Daniela ;

Veschini, Lorenzo ;

Foglieni, Chiara ;

Dell'Antonio, Giacomo ;

Caligaris-Cappio, Federico ;

Ferrarini, Marina ;

Ferrero, Elisabetta .

EXPERIMENTAL CELL RESEARCH, 2010, 316 (06) :1010-1018

[6] Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib [J].

Bocci, G. ;

Falcone, A. ;

Fioravanti, A. ;

Orlandi, P. ;

Di Paolo, A. ;

Fanelli, G. ;

Viacava, P. ;

Naccarato, A. G. ;

Kerbel, R. S. ;

Danesi, R. ;

Del Tacca, M. ;

Allegrini, G. .

BRITISH JOURNAL OF CANCER, 2008, 98 (10) :1619-1629

[7] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].

Boehm, T ;

Folkman, J ;

Browder, T ;

OReilly, MS .

NATURE, 1997, 390 (6658) :404-407

[8]

Browder T, 2000, CANCER RES, V60, P1878

[9] How molecular imaging is speeding up antiangiogenic drug development [J].

Cai, Weibo ;

Rao, Jianghong ;

Gambhir, Sanjiv S. ;

Chen, Xiaoyuan .

MOLECULAR CANCER THERAPEUTICS, 2006, 5 (11) :2624-2633

[10] A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer [J].

Cao, Yunfei ;

Tan, Aihua ;

Gao, Feng ;

Liu, Lidan ;

Liao, Cun ;

Mo, Zengnan .

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (06) :677-685

← 1 2 3 4 5 6 7 →